Intelligent Bio Solutions Inc. Cash Flow-to-Debt Ratio
Intelligent Bio Solutions Inc. cash flow-to-debt ratio. Intelligent Bio Solutions Inc. (INBS) has a Cash Flow-to-Debt Ratio of -0.48x as of June 2026, meaning its operating cash flow of $-3.18 Million could theoretically repay 0% of its total liabilities ($6.65 Million) in one year. See how financially flexible is Intelligent Bio Solutions Inc. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Intelligent Bio Solutions Inc. (2017–2026)
Cash flow-to-debt ratio of Intelligent Bio Solutions Inc. from 2017 to 2026. Historical debt coverage capacity for Intelligent Bio Solutions Inc. across 10 annual periods. Check cash flow reinvestment rate of Intelligent Bio Solutions Inc. to assess the company's total reinvestment commitment from operating cash flow.
Intelligent Bio Solutions Inc. Cash Flow-to-Debt Ratio by Year (2017–2026)
Intelligent Bio Solutions Inc. cash flow-to-debt ratio by year from 2017 to 2026. Year-by-year debt coverage analysis for Intelligent Bio Solutions Inc.. For the full cash flow conversion analysis, see INBS cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -1.79x | $-11.93 Million | $6.65 Million | ▼ -0.7% |
| 2025 | -1.78x | $-9.68 Million | $5.44 Million | ▼ -4.1% |
| 2024 | -1.71x | $-9.57 Million | $5.60 Million | ▼ -54.6% |
| 2023 | -1.11x | $-7.38 Million | $6.67 Million | ▼ -91.3% |
| 2022 | -0.58x | $-3.36 Million | $5.81 Million | ▲ +64.9% |
| 2021 | -1.65x | $-11.30 Million | $6.85 Million | ▼ -2442.5% |
| 2020 | -0.06x | $-498.62K | $7.69 Million | ▲ +92.7% |
| 2019 | -0.88x | $-5.58 Million | $6.31 Million | ▲ +8.7% |
| 2018 | -0.97x | $-5.38 Million | $5.56 Million | ▼ -2513.0% |
| 2017 | -0.04x | $-243.89K | $6.58 Million | — |